Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2031

Report ID: 1380343 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Gastrointestinal OTC Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Laxatives
        1.2.3 Anti-Flatulents
        1.2.4 H2-Antaginists
        1.2.5 Anti-Diarrheals
        1.2.6 PPIs
        1.2.7 Anti-Emetics
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Gastrointestinal OTC Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Gastrointestinal OTC Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Gastrointestinal OTC Drugs Sales by Region
        2.4.1 Global Gastrointestinal OTC Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Gastrointestinal OTC Drugs by Region (2023-2028)
    2.5 Global Gastrointestinal OTC Drugs Revenue by Region
        2.5.1 Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022)
        2.5.2 Global Gastrointestinal OTC Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers
        3.1.1 Global Top Gastrointestinal OTC Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gastrointestinal OTC Drugs in 2021
    3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturers
        3.2.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2021
    3.3 Global Gastrointestinal OTC Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Gastrointestinal OTC Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Gastrointestinal OTC Drugs Sales by Type
        4.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Gastrointestinal OTC Drugs Revenue by Type
        4.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Gastrointestinal OTC Drugs Price by Type
        4.3.1 Global Gastrointestinal OTC Drugs Price by Type (2017-2022)
        4.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Gastrointestinal OTC Drugs Sales by Application
        5.1.1 Global Gastrointestinal OTC Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Gastrointestinal OTC Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Gastrointestinal OTC Drugs Revenue by Application
        5.2.1 Global Gastrointestinal OTC Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Gastrointestinal OTC Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Gastrointestinal OTC Drugs Price by Application
        5.3.1 Global Gastrointestinal OTC Drugs Price by Application (2017-2022)
        5.3.2 Global Gastrointestinal OTC Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal OTC Drugs Market Size by Type
        6.1.1 North America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
        6.1.2 North America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
    6.2 North America Gastrointestinal OTC Drugs Market Size by Application
        6.2.1 North America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
        6.2.2 North America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
    6.3 North America Gastrointestinal OTC Drugs Market Size by Country
        6.3.1 North America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
        6.3.2 North America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Gastrointestinal OTC Drugs Market Size by Type
        7.1.1 Europe Gastrointestinal OTC Drugs Sales by Type (2017-2028)
        7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
    7.2 Europe Gastrointestinal OTC Drugs Market Size by Application
        7.2.1 Europe Gastrointestinal OTC Drugs Sales by Application (2017-2028)
        7.2.2 Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
    7.3 Europe Gastrointestinal OTC Drugs Market Size by Country
        7.3.1 Europe Gastrointestinal OTC Drugs Sales by Country (2017-2028)
        7.3.2 Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Gastrointestinal OTC Drugs Market Size by Type
        8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Application
        8.2.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
        8.3.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Gastrointestinal OTC Drugs Market Size by Type
        9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
    9.2 Latin America Gastrointestinal OTC Drugs Market Size by Application
        9.2.1 Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
    9.3 Latin America Gastrointestinal OTC Drugs Market Size by Country
        9.3.1 Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Type
        10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Application
        10.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Country
        10.3.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Corporation Information
        11.1.2 GlaxoSmithKline Overview
        11.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GlaxoSmithKline Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Corporation Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Bayer
        11.4.1 Bayer Corporation Information
        11.4.2 Bayer Overview
        11.4.3 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bayer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bayer Recent Developments
    11.5 Procter & Gamble
        11.5.1 Procter & Gamble Corporation Information
        11.5.2 Procter & Gamble Overview
        11.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Procter & Gamble Recent Developments
    11.6 Perrigo
        11.6.1 Perrigo Corporation Information
        11.6.2 Perrigo Overview
        11.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Perrigo Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Perrigo Recent Developments
    11.7 Abbott
        11.7.1 Abbott Corporation Information
        11.7.2 Abbott Overview
        11.7.3 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Abbott Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Abbott Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Corporation Information
        11.8.2 Sanofi Overview
        11.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sanofi Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sanofi Recent Developments
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Corporation Information
        11.9.2 Teva Pharmaceutical Overview
        11.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teva Pharmaceutical Recent Developments
    11.10 Nestle
        11.10.1 Nestle Corporation Information
        11.10.2 Nestle Overview
        11.10.3 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Nestle Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Nestle Recent Developments
    11.11 Boehringer Ingelheim
        11.11.1 Boehringer Ingelheim Corporation Information
        11.11.2 Boehringer Ingelheim Overview
        11.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Boehringer Ingelheim Recent Developments
    11.12 Reckitt Benckiser
        11.12.1 Reckitt Benckiser Corporation Information
        11.12.2 Reckitt Benckiser Overview
        11.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Reckitt Benckiser Recent Developments
    11.13 Purdue Pharma
        11.13.1 Purdue Pharma Corporation Information
        11.13.2 Purdue Pharma Overview
        11.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Purdue Pharma Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Purdue Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Gastrointestinal OTC Drugs Industry Chain Analysis
    12.2 Gastrointestinal OTC Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Gastrointestinal OTC Drugs Production Mode & Process
    12.4 Gastrointestinal OTC Drugs Sales and Marketing
        12.4.1 Gastrointestinal OTC Drugs Sales Channels
        12.4.2 Gastrointestinal OTC Drugs Distributors
    12.5 Gastrointestinal OTC Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Gastrointestinal OTC Drugs Industry Trends
    13.2 Gastrointestinal OTC Drugs Market Drivers
    13.3 Gastrointestinal OTC Drugs Market Challenges
    13.4 Gastrointestinal OTC Drugs Market Restraints
14 Key Findings in The Global Gastrointestinal OTC Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Laxatives
    Table 3. Major Manufacturers of Anti-Flatulents
    Table 4. Major Manufacturers of H2-Antaginists
    Table 5. Major Manufacturers of Anti-Diarrheals
    Table 6. Major Manufacturers of PPIs
    Table 7. Major Manufacturers of Anti-Emetics
    Table 8. Major Manufacturers of Other
    Table 9. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Gastrointestinal OTC Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 12. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022)
    Table 13. Global Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2023-2028)
    Table 15. Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2022)
    Table 17. Global Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2023-2028)
    Table 19. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 20. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2017-2022)
    Table 21. Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2017-2022)
    Table 23. Gastrointestinal OTC Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 24. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2021)
    Table 26. Gastrointestinal OTC Drugs Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Gastrointestinal OTC Drugs Product Offered
    Table 28. Date of Manufacturers Enter into Gastrointestinal OTC Drugs Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 31. Global Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 32. Global Gastrointestinal OTC Drugs Sales Share by Type (2017-2022)
    Table 33. Global Gastrointestinal OTC Drugs Sales Share by Type (2023-2028)
    Table 34. Global Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Gastrointestinal OTC Drugs Revenue Share by Type (2017-2022)
    Table 37. Global Gastrointestinal OTC Drugs Revenue Share by Type (2023-2028)
    Table 38. Gastrointestinal OTC Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 39. Global Gastrointestinal OTC Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 40. Global Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 41. Global Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 42. Global Gastrointestinal OTC Drugs Sales Share by Application (2017-2022)
    Table 43. Global Gastrointestinal OTC Drugs Sales Share by Application (2023-2028)
    Table 44. Global Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Gastrointestinal OTC Drugs Revenue Share by Application (2017-2022)
    Table 47. Global Gastrointestinal OTC Drugs Revenue Share by Application (2023-2028)
    Table 48. Gastrointestinal OTC Drugs Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Global Gastrointestinal OTC Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 50. North America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 51. North America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 52. North America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 55. North America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 56. North America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 59. North America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 60. North America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 63. Europe Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 64. Europe Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 67. Europe Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 68. Europe Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 71. Europe Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 72. Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 75. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 76. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 79. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 80. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 83. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
    Table 84. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 87. Latin America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 88. Latin America Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 91. Latin America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 92. Latin America Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 95. Latin America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 96. Latin America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 99. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
    Table 100. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
    Table 103. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
    Table 104. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 107. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
    Table 108. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Major Businesses
    Table 112. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 113. GlaxoSmithKline Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Pfizer Corporation Information
    Table 116. Pfizer Description and Major Businesses
    Table 117. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 118. Pfizer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Pfizer Recent Developments
    Table 120. Johnson & Johnson Corporation Information
    Table 121. Johnson & Johnson Description and Major Businesses
    Table 122. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 123. Johnson & Johnson Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Johnson & Johnson Recent Developments
    Table 125. Bayer Corporation Information
    Table 126. Bayer Description and Major Businesses
    Table 127. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 128. Bayer Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Bayer Recent Developments
    Table 130. Procter & Gamble Corporation Information
    Table 131. Procter & Gamble Description and Major Businesses
    Table 132. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 133. Procter & Gamble Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Procter & Gamble Recent Developments
    Table 135. Perrigo Corporation Information
    Table 136. Perrigo Description and Major Businesses
    Table 137. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 138. Perrigo Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Perrigo Recent Developments
    Table 140. Abbott Corporation Information
    Table 141. Abbott Description and Major Businesses
    Table 142. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 143. Abbott Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Abbott Recent Developments
    Table 145. Sanofi Corporation Information
    Table 146. Sanofi Description and Major Businesses
    Table 147. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 148. Sanofi Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Sanofi Recent Developments
    Table 150. Teva Pharmaceutical Corporation Information
    Table 151. Teva Pharmaceutical Description and Major Businesses
    Table 152. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 153. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Teva Pharmaceutical Recent Developments
    Table 155. Nestle Corporation Information
    Table 156. Nestle Description and Major Businesses
    Table 157. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 158. Nestle Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Nestle Recent Developments
    Table 160. Boehringer Ingelheim Corporation Information
    Table 161. Boehringer Ingelheim Description and Major Businesses
    Table 162. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 163. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Boehringer Ingelheim Recent Developments
    Table 165. Reckitt Benckiser Corporation Information
    Table 166. Reckitt Benckiser Description and Major Businesses
    Table 167. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 168. Reckitt Benckiser Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Reckitt Benckiser Recent Developments
    Table 170. Purdue Pharma Corporation Information
    Table 171. Purdue Pharma Description and Major Businesses
    Table 172. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 173. Purdue Pharma Gastrointestinal OTC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Purdue Pharma Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Gastrointestinal OTC Drugs Distributors List
    Table 178. Gastrointestinal OTC Drugs Customers List
    Table 179. Gastrointestinal OTC Drugs Market Trends
    Table 180. Gastrointestinal OTC Drugs Market Drivers
    Table 181. Gastrointestinal OTC Drugs Market Challenges
    Table 182. Gastrointestinal OTC Drugs Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal OTC Drugs Product Picture
    Figure 3. Global Gastrointestinal OTC Drugs Market Share by Type in 2021 & 2028
    Figure 3. Laxatives Product Picture
    Figure 4. Anti-Flatulents Product Picture
    Figure 5. H2-Antaginists Product Picture
    Figure 6. Anti-Diarrheals Product Picture
    Figure 7. PPIs Product Picture
    Figure 8. Anti-Emetics Product Picture
    Figure 9. Other Product Picture
    Figure 10. Global Gastrointestinal OTC Drugs Market Share by Application in 2021 & 2028
    Figure 11. Hospital Pharmacies
    Figure 12. Retail Pharmacies
    Figure 13. Online Pharmacies
    Figure 14. Gastrointestinal OTC Drugs Report Years Considered
    Figure 15. Global Gastrointestinal OTC Drugs Sales 2017-2028 (K Pcs)
    Figure 16. Global Gastrointestinal OTC Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Gastrointestinal OTC Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 22. North America Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Europe Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Asia-Pacific Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Latin America Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Gastrointestinal OTC Drugs Sales YoY (2017-2028) & (K Pcs)
    Figure 30. Middle East & Africa Gastrointestinal OTC Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Gastrointestinal OTC Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Gastrointestinal OTC Drugs in the World: Market Share by Gastrointestinal OTC Drugs Revenue in 2021
    Figure 33. Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
    Figure 44. U.S. Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Gastrointestinal OTC Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Gastrointestinal OTC Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
    Figure 78. Latin America Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
    Figure 79. Mexico Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Gastrointestinal OTC Drugs Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Gastrointestinal OTC Drugs Revenue Share by Country (2017-2028)
    Figure 88. Turkey Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Gastrointestinal OTC Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. Gastrointestinal OTC Drugs Value Chain
    Figure 92. Gastrointestinal OTC Drugs Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Frequently Asked Questions
Gastrointestinal OTC Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal OTC Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal OTC Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports